12-45331305-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001025356.3(ANO6):āc.161A>Gā(p.Asn54Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00032 in 1,609,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001025356.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANO6 | NM_001025356.3 | c.161A>G | p.Asn54Ser | missense_variant | 3/20 | ENST00000320560.13 | NP_001020527.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANO6 | ENST00000320560.13 | c.161A>G | p.Asn54Ser | missense_variant | 3/20 | 1 | NM_001025356.3 | ENSP00000320087 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152028Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000482 AC: 12AN: 249122Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134770
GnomAD4 exome AF: 0.000340 AC: 496AN: 1456880Hom.: 0 Cov.: 30 AF XY: 0.000346 AC XY: 251AN XY: 724630
GnomAD4 genome AF: 0.000125 AC: 19AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74386
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2023 | The c.161A>G (p.N54S) alteration is located in exon 3 (coding exon 3) of the ANO6 gene. This alteration results from a A to G substitution at nucleotide position 161, causing the asparagine (N) at amino acid position 54 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 10, 2022 | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 54 of the ANO6 protein (p.Asn54Ser). This variant is present in population databases (rs200785570, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with ANO6-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ANO6 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at